Fluorescence Guided Surgery Systems Market Analysis

Application (Cancer Surgery, Neurosurgery, Ophthalmic Surgery, Cardiac Surgery)

In fluorescence guided surgery systems market, cancer surgery segment is set to cross USD 63.4% billion by 2037. The growing incidences of cancer and fatalities across the world are creating a surge in new and more effective treatment methods. According to a report published by WHO, in February 2024, the estimated number of new cancer and related death cases reached 20 million and 9.7 million respectively in 2022. The total amount of new cases was followed by 2.5 million lung cancer, 2.3 million breast cancer, 1.9 million colorectal cancer, 1.5 million prostate cancer, and 0.9 million stomach cancer. Thus, FGS has become a revolutionary technique in the surgical world for treating such chronic diseases, driving growth in this segment.

Type (Radioactive Tracers, Near-Infrared (NIR) Tracers, Visible Light Tracers)

In terms of type, the radioactive tracers segment is estimated to hold a significant share of the fluorescence guided surgery systems market by the end of 2037. The growth in this segment is attributed to the rising demand for minimally invasive procedures such as Laparoscopy and technological advancements in surgical imaging techniques such as robotic surgery. According to a Research Nester report, the surgical robots market is projected to reach USD 12.5 billion by 2036. The radioactive tracers are capable of transmitting signals even from deeper layers of tissue, making them preferable for precise lesion localization. Such abilities are further driving demand in this segment due to fewer challenges and better patient outcomes during operations.

Our in-depth analysis of the fluorescence guided surgery systems market includes the following segments:

Application	Cancer Surgery Neurosurgery Ophthalmic Surgery Cardiac Surgery
Type	Radioactive Tracers Near-Infrared (NIR) Tracers Visible Light Tracers
End use	Hospitals Academic Institutions Research Laboratories Clinical Trials
Imaging Modalities	Fluorescence Endoscopy Fluorescence Microscopy Fluorescence-Guided Laparoscopy
Target Population	Patients with Cancer Neurosurgical Patients Ophthalmic Patients Cardiac Patients

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the fluorescence guided surgery systems market was estimated at over USD 1.9 billion.

The market size for the fluorescence guided surgery systems market is projected to reach USD 4.1 billion by the end of 2037 expanding at a CAGR of 6.8% during the forecast period i.e., between 2025-2037.

The major players in the market are Xinrui Medical Tech Co., Ltd., Medtronic, Ziehm Imaging GmbH, VisionSense Technologies, Inc., DEUtron Health, Synaptive Medical Inc., AHN Biotechnologie GmbH, Fluoptics Technologies, Inc., MultiPlanar Imaging, LLC, Accuray Incorporated, Stryker Corporation, Leica Microsystems GmbH, Hologic, Inc., and others.

In terms of applications, the cancer surgery segment is anticipated to garner the largest market share of 63.4% by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 58.5% by the end of 2037 and provide more business opportunities in the future.

Fluorescence Guided Surgery Systems Market Analysis